SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Argos Therapeutics, Inc. (ARGS)

ARGS RSS Feed
Add ARGS Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 9/26/2017 5:26:51 AM - Followers: 53 - Board type: Free - Posts Today: 1

Argos Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of personalized immunotherapies for the treatment of cancer and infectious diseases. The company develops immunotherapies based on Arcelis, its proprietary technology platform. Its products include AGS-003, which is under Phase III clinical trials and intended for the treatment of metastatic renal cell carcinoma (clear cell); and AGS-004, which is under Phase IIb clinical trials and is intended for the treatment of Human Immunodeficiency Virus. The company also develops AGS-003 for metastatic renal cell carcinoma (non-clear cell), early stage RCC, and other solid tumors. The company was formerly known as Merix Bioscience, Inc. and changed its name to Argos Therapeutics, Inc. in October 2004. Argos Therapeutics, Inc. was founded in 1997 and is headquartered in Durham, North Carolina.(yahoo)
SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
ARGS
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ARGS News: Current Report Filing (8-k) 09/25/2017 08:31:26 AM
ARGS News: Argos Therapeutics to Hold Conference Call to Discuss Update on the Phase 3 ADAPT Trial Presented at the ESMO 2017 Congress 09/19/2017 08:30:00 AM
ARGS News: Current Report Filing (8-k) 09/12/2017 08:31:58 AM
ARGS News: Argos Therapeutics Reports on Interim Analysis of Phase 3 ADAPT Trial Presented at ESMO 2017 Congress 09/12/2017 08:00:00 AM
ARGS News: Argos Announces First Dosing of HIV Patient with AGS-004 Derived from the Latent Viral Reservoir 09/06/2017 08:00:00 AM
News News Alert: Current Report Filing (8-k) 09/25/2017 08:31:26 AM
PostSubject
#613   Thx for your heads-up. Didn´t want to offend Klinsmann 09/26/17 05:26:51 AM
#612   Sorry, but it's difficult to agree with your TheShadow 09/25/17 09:21:53 PM
#611   Lets break ,18... and move to ,25 declaes 09/25/17 01:19:37 PM
#610   PS - RS is seldom good news if Klinsmann 09/23/17 12:56:12 AM
#609   Sorry, but difficult to unterstand your post... To Klinsmann 09/23/17 12:52:19 AM
#608   Good news if they RS split to stay listed. TheShadow 09/22/17 08:25:15 AM
#607   Breking ,18 soon again today imo... declaes 09/21/17 10:58:37 AM
#606   I don´t see a change in state of Klinsmann 09/21/17 09:37:40 AM
#605   I am not an employee of the company, bigl0u 09/21/17 09:27:47 AM
#604   Indeed! That´s the reason I´ve bought a chunk Klinsmann 09/21/17 08:34:15 AM
#603   Exactly, I think yesterday's CC wasn't bad at TheInvincibleBull 09/21/17 08:24:28 AM
#602   So when the independent data monitoring committee (DMC) declaes 09/21/17 03:38:06 AM
#601   I'm out. MR 1955 DOUBLE DIE 09/20/17 08:31:26 PM
#600   * * $ARGS Video Chart Analysis 9/20/17 * * ClayTrader 09/20/17 05:46:47 PM
#599   Looking very promising but Nothing new on the declaes 09/20/17 05:00:56 PM
#598   Conference Call AH - only up from here imo Klinsmann 09/20/17 03:59:28 PM
#597   1,000,000 bid at 0.19...hmmm declaes 09/20/17 03:53:24 PM
#596   Looks like! Still lots of dumping, but shorts Klinsmann 09/20/17 01:06:06 PM
#595   Squeeze coming zzking617 09/20/17 12:31:27 PM
#594   Most likely good news. michaeldesanta 09/20/17 11:32:56 AM
#593   So far just very nice predictable trading on Klinsmann 09/20/17 11:29:46 AM
#592   So expecting good news tonight? Tanx D declaes 09/20/17 11:26:12 AM
#591   $ARGS The ESMO presentation went well and the michaeldesanta 09/20/17 11:16:29 AM
#590   Here we goooo :) Klinsmann 09/20/17 09:52:29 AM
#589   In again for next 20-30% gains Klinsmann 09/19/17 11:35:40 AM
#588   does anyone know when the reverse split is amablex 09/16/17 10:10:50 PM
#587   Thanks man, I guess that's the best way Luchador 09/15/17 05:19:27 PM
#586   It's a bio, who knows what's going to BigBlackDog 09/15/17 05:18:21 PM
#585   Is there any positive outlook for this company Luchador 09/15/17 04:04:41 PM
#584   It's time for this bounce!!! BigBlackDog 09/15/17 09:33:48 AM
#583   how is paul mamphilly crackmen2 09/13/17 05:57:05 PM
#582   bought just before earnings at 5.00, just sold crackmen2 09/13/17 05:56:15 PM
#581   Pharmstandard has over 18 million in converted shares TheShadow 09/11/17 07:32:36 PM
#580   To low .40 . $200 on share keren 09/10/17 03:38:21 PM
#579   Lets sell ARGS for $200 on share. keren 09/10/17 03:31:13 PM
#578   Thanks Clay KelliBlue 09/07/17 10:58:30 AM
#577   ARGS occupies a small percentage of my portfolio TheShadow 09/06/17 07:43:36 PM
#576   * * $ARGS Video Chart 09-06-17 * * ClayTrader 09/06/17 05:12:22 PM
#575   A trap for those who´ve bought under 0,20 Klinsmann 09/06/17 10:31:37 AM
#574   a trap? looks like juancarlos 09/06/17 10:20:19 AM
#573   This should see .30-.40 very soon. djnicky07 09/06/17 10:17:15 AM
#572   Buys coming in at .20 Attila1905 09/01/17 10:19:57 AM
#571   Do we have a date on the R/s yet? TheInvincibleBull 08/30/17 04:46:04 PM
#570   Reverse split coming and S3 is filed. deadjim 08/25/17 06:46:27 PM
#569   BUY THIS, DO IT... TRACING 08/25/17 02:05:11 AM
#568   .40 Target VERITAS77 08/21/17 09:31:27 PM
#567   S3 out. Capital raise at .23c. What a turd deadjim 08/16/17 05:21:39 PM
#566   No chasing here and no holding bags, me jones99 08/10/17 04:51:47 AM
#565   Bottom building here as it seems... Klinsmann 08/07/17 01:13:39 PM
#564   Yes, all items passed including RS see 8k Eltp 08/03/17 11:43:01 PM
PostSubject